Drawing for BECAUSE EVERY TEST IS A LIFE

USPTO serial 88854856

BECAUSE EVERY TEST IS A LIFE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
FERRER PEREZ, PAUL ANTHONY
Law office
DIVISIONAL UNIT

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BECAUSE EVERY TEST IS A LIFE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alexis Crawford Douglas

Alexis Crawford Douglas K&L GATES LLPP.O. BOX 1135CHICAGO, IL 60690-1135UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic assays and reagents for blood and plasma research purposes; diagnostic assays and reagents for chemical and laboratory useACTIVE—
005Medical diagnostic assays and reagents for testing and screening of blood and plasmaACTIVE—
009Downloadable computer software and recorded computer software for use in diagnostic testing, screening, and management of blood and plasma, namely, software that allows blood and plasma information to be recorded and maintained, instruments to be monitored, and quality control to be managed; software used by laboratories in connection with immunohematology analyzers, namely, a downloadable software program and a recorded software program that assists the operator in effectively performing the required testing on the immunohematology analyzers, run via computer; computer hardware used by laboratories in connection with immunohematology analyzers that assists the operator in effectively performing the required testing on the immunohematology analyzers, run via computerACTIVE—
010Medical equipment, namely, chemistry analyzer apparatus used to generate diagnostic test results from blood and other body fluids by professionals in hospitals, laboratories, clinics and doctors' offices; Blood testing apparatus; Apparatus and medical diagnostic instruments for blood analysis; Medical diagnostic equipment and instruments, namely, immunohematology analyzer apparatus for blood screening, blood typing, detection of assays associated with blood screening and blood typing used in the transfusion medicine marketACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 16, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 15, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 17, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 15, 2023EX4GSOU EXTENSION 4 GRANTED—
Jun 15, 2023EXT4SOU EXTENSION 4 FILED—
Jun 15, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 17, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 15, 2022EX3GSOU EXTENSION 3 GRANTED—
Dec 15, 2022EXT3SOU EXTENSION 3 FILED—
Dec 15, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 15, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 13, 2022EX2GSOU EXTENSION 2 GRANTED—
Jun 13, 2022EXT2SOU EXTENSION 2 FILED—
Jun 13, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 14, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 14, 2022NOACCORRECTED NOA E-MAILED—
Jan 13, 2022EX1GSOU EXTENSION 1 GRANTED—
Jan 13, 2022DPCCDIVISIONAL PROCESSING COMPLETE—
Jan 3, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 15, 2021EXT1SOU EXTENSION 1 FILED—
Dec 15, 2021DRRRDIVISIONAL REQUEST RECEIVED—
Dec 15, 2021ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Dec 15, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 15, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 20, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 20, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 31, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 16, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 16, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Mar 16, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 16, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 16, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 15, 2021ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Mar 9, 2021PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Feb 19, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 18, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 18, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 17, 2021ALIEASSIGNED TO LIE—
Nov 12, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 6, 2020GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jul 6, 2020GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jul 6, 2020CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jun 19, 2020DOCKASSIGNED TO EXAMINER—
Apr 7, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 3, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance